New study targets lethal fungal infection

July 24, 2017, University of Queensland
UQ study targets lethal fungal infection
Crystal structure at 2.1 Å resolution of the target enzyme, ADS lyase. The inset shows detailed structure of the active site. Credit: University of Queensland

The development of new drugs to fight a common fungal pathogen which kills half a million people globally each year is a step closer thanks to a University of Queensland-led study.

UQ PhD student Jessica Chitty of the Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, said the study targeted the fungus Cryptococcus neoformans, which had shown signs of becoming resistant to current medications.

"This is a fungus that can be found around the world and when inhaled, its microscopic cells can cause in people with a weakened immune system," she said.

"Infections are particularly prevalent in people with advanced AIDS but can also occur in transplant recipients and those on .

"Recently two rare cases of Cryptococcus neoformans infections occurred in Australia in immunocompetent people."

Co-author Associate Professor James Fraser said drugs used to treat the disease have been around for a few decades and consequently resistance had become a problem in the treatment of infection.

"The current antifungals we have are ineffective and require close monitoring of the patients," he said.

"Our lab is looking for new drug targets. Fungi are much more closely related to humans, so a drug that kills fungi is probably just as good at killing humans.

"Instead we are examining subtle differences in enzymes that are shared between fungi and humans."

Researchers are targeting an enzyme in the fungus that has a dual role in a pathway necessary for human and to make DNA, and consequently to grow.

"If we can stop the enzyme, we can stop both jobs it performs at once, and therefore stop new cells being made," Ms Chitty said.

"But because it is an enzyme shared by both the disease-causing fungus, and a human host, we need to look for differences between the two so that a new only stops the fungal from functioning."

Explore further: Scientists discover bird blood cell which destroys fatal fungal infection

More information: Jessica L. Chitty et al. Cryptococcus neoformansADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design, Journal of Biological Chemistry (2017). DOI: 10.1074/jbc.M117.787994

Related Stories

Scientists discover bird blood cell which destroys fatal fungal infection

February 17, 2016
Scientists have discovered that a specialised white blood cell found in birds can destroy a potentially fatal fungal infection which affects more than one million people every year.

Angina drug could inform a new strategy to fight cryptococcosis

June 7, 2016
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.

Predicting fatal fungal infections

June 16, 2009
In a study published in The Journal of Infectious Diseases, researchers from Albert Einstein College of Medicine of Yeshiva University have identified cells in blood that predict which HIV-positive individuals are most likely ...

Patented compound kills various human pathogenic fungi, may improve human health

April 30, 2015
A now-patented substance from two Kansas State University researchers may be an all-purpose solution for stopping fungus.

New study finds titan cells protect Cryptococcus

May 28, 2012
Giant cells called "titan cells" protect the fungus Cryptococcus neoformans during infection, according to two University of Minnesota researchers. Kirsten Nielsen, Ph.D., an assistant professor in the department of microbiology, ...

How a deadly fungus evades the immune system

March 31, 2015
New research from the University of Toronto has scientists re-thinking how a lethal fungus grows and kills immune cells. The study hints at a new approach to therapy for Candida albicans, one of the most common causes of ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.